“…The incidence increases with doses up to 3 Gy and the symptoms of the affected mice are similar to those found in human AML (Upton et al, 1958;Major, 1979;Mole et al, 1983;Resnitzky et al, 1985;Seki et al, 1991). The leukaemic cells usually carry a deletion of chromosome 2 (Hayata et al, 1983;Trakhtenbrot et al, 1988;Rithidech et al, 1993;Clark et al, 1996) and a mutation of the Sfpi1 gene on the retained homologue (Cook et al, 2004;Suraweera et al, 2005;Hirouchi et al, 2008).…”